Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
76,378,254
-
Total 13F shares
-
8,861,181
-
Share change
-
+7,599,920
-
Total reported value
-
$177,430,838
-
Price per share
-
$20.27
-
Number of holders
-
43
-
Value change
-
+$151,864,801
-
Number of buys
-
42
Institutional Holders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) as of Q4 2020
As of 31 Dec 2020,
Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,861,181 shares.
The largest 10 holders included
FMR LLC, Euclidean Capital LLC, Cormorant Asset Management, LP, BlackRock Inc., Monashee Investment Management LLC, Alphabet Inc., VANGUARD GROUP INC, Birchview Capital, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, and Casdin Capital, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.